Shapovalenko TV, Zinchenko NM, Imanmadiyeva DM, Dolinnaya VT Drug therapy for the treatment of chronic heart failure and concomitant diseases // Medikation in der Behandlung der chronischen Herzinsuffizienz und Begleiterkrankungen Zeitschrift für Gefäßmedizin 2020; 17 (4): 12-21 Volltext (PDF) Summary Übersicht
| ||||||
Abbildung 2: Coenzyme Q10 Effects of coenzyme Q10 on cardiac dyssynchronicity in the patients with ischemic chronic heart failure with preserved LV ejection fraction (EF > 40%), type 2 diabetes mellitus and myocardial dyssynchronicity. *Significance level (p < 0.05) compared to diastolic function in the patients on standard therapy |
![]()
Abbildung 2: Coenzyme Q10
Effects of coenzyme Q10 on cardiac dyssynchronicity in the patients with ischemic chronic heart failure with preserved LV ejection fraction (EF > 40%), type 2 diabetes mellitus and myocardial dyssynchronicity. *Significance level (p < 0.05) compared to diastolic function in the patients on standard therapy |